MiCAN Technologies
Developing blood cells for research purposes, specifically for studying and developing treatments for covid-19. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€6—8m (Dealroom.co estimates Aug 2023.)
Kyoto Kyoto Prefecture (HQ)
Authorizing premium user...